Adicet Bio (NASDAQ:ACET) shares gained in early trading on Monday after the U.S. drug regulator cleared the company’s Investigational New Drug (IND) application to evaluate its CAR T cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback